ADIPOQ and coronary artery disorder: In addition, some studies demonstrated that circulating adiponectin is significantly associated with the onset of coronary artery disease and myocardial infarction in subjects below the age of 60 [23,24], and all cause/cardio-vascular disease (CVD) mortality [25].